Results
Barbara Ann Karmanos Cancer Institute
03/24/2025 | Press release | Archived content
IN THE NEWS: Dr. Zonder on the Need for Increased Awareness in Multiple Myeloma
March 24, 2025
OncLive
Multiple myeloma is one of the most commonly diagnosed hematologic cancers, but as Jeffrey Zonder, M.D., hematologist, leader of the Multiple Myeloma and Amyloidosis Multidisciplinary Team (MDT) and member of the Hematology Oncology MDT at Karmanos, explained, many people don't know what it is.
Watch the interview here.
Barbara Ann Karmanos Cancer Institute published this content on March 24, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 11, 2025 at 12:07 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]